search button

Identification and validation of core genes for serous ovarian adenocarcinoma via bioinformatics analysis

  • Authors:
    • Ruru Zhu
    • Jisen Xue
    • Huijun Chen
    • Qian Zhang

  • View Affiliations

  • Published online on: August 21, 2020     https://doi.org/10.3892/ol.2020.12007
  • Article Number: 145
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Ovarian cancer is a fatal gynaecological malignancy in women worldwide, and serous ovarian cancer (SOC) is considered the most common histological subtype of this malignancy. Thus, the present study aimed to identify the core genes for SOC via bioinformatics analysis. The GSE18520 and GSE14407 datasets were downloaded from the Gene Expression Omnibus (GEO) database to screen for differentially expressed genes (DEGs) and perform gene set enrichment analysis (GSEA). A protein‑protein interaction (PPI) network was constructed to identify the core genes, while The Cancer Genome Atlas (TCGA) database was used to screen for prognosis‑associated DEGs. Furthermore, clinical samples were collected for further validation of kinesin family member 11 (KIF11) gene. In the GEO analysis, a total of 198 DEGs were identified, including 81 upregulated and 117 downregulated genes compared SOC to normal tissue. GSEA across the two datasets demonstrated that 16 gene sets, including those involved in the cell cycle and DNA replication, were notably associated with SOC. A PPI network of the DEGs was constructed with 130 nodes and 387 edges. Subsequently, 20 core genes involved in the same top‑ranked module were filtered out by submodule analysis. Survival analysis identified three predictive genes for SOC prognosis, including KIF11, CLDN3 and FGF13. KIF11 was identified as a core and predictive gene and thus was further validated using clinical samples. The results demonstrated that KIF11 was upregulated in tumour tissues compared with adjacent normal tissues and was associated with aggressive factors, including tumour grade, TNM stage and lymph node invasion. In conclusions, the present study identified the core genes and gene sets for SOC, thus extending the understanding of SOC occurrence and progression. Furthermore, KIF11 was identified as a promising tumour‑promoting gene and a potential target for the diagnosis and treatment of SOC.
View Figures
View References

Related Articles

Journal Cover

November-2020
Volume 20 Issue 5

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 2.5
  • Ranked Oncology
    (total number of cites)
  • CiteScore: 5.7
  • CiteScore Rank: Q2: #139/404 Oncology
  • Source Normalized Impact per Paper (SNIP): 0.574
  • SCImago Journal Rank (SJR): 0.644
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Zhu R, Xue J, Chen H and Zhang Q: Identification and validation of core genes for serous ovarian adenocarcinoma via bioinformatics analysis. Oncol Lett 20: 145, 2020.
APA
Zhu, R., Xue, J., Chen, H., & Zhang, Q. (2020). Identification and validation of core genes for serous ovarian adenocarcinoma via bioinformatics analysis. Oncology Letters, 20, 145. https://doi.org/10.3892/ol.2020.12007
MLA
Zhu, R., Xue, J., Chen, H., Zhang, Q."Identification and validation of core genes for serous ovarian adenocarcinoma via bioinformatics analysis". Oncology Letters 20.5 (2020): 145.
Chicago
Zhu, R., Xue, J., Chen, H., Zhang, Q."Identification and validation of core genes for serous ovarian adenocarcinoma via bioinformatics analysis". Oncology Letters 20, no. 5 (2020): 145. https://doi.org/10.3892/ol.2020.12007